The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic Screen.
暂无分享，去创建一个
L. LeBrun | Dan Zhu | B. Pagarigan | P. Chamberlain | T. Tran | K. Leftheris | D. Cashion | Ming Chen | J. Riggs | Andrew Calabrese | M. Moghaddam | P. Erdman | J. Boylan | L. Tehrani | Dehua Huang | J. Katz | S. Delker | Mark A. Nagy | L. Barnes | R. Narla | Gordafaried Deyanat-Yazdi | Roy L. Harris | S. Bahmanyar | Yang Tang | Stacie Canan | J. Elsner | D. Robinson | Xiaohui Peng | Terra Miller | Stacie S Canan | Leo A. Barnes